MMP9 and breast carcinoma: Zymomonas' levan is involved in MMP-9 activation and extracellular matrix remodeling and inflammation (Sturzoiu et al., 2011) and also to induce changes in oxidative states leading to antiproliferative and proapoptotic effects in MCF7 breast cancer cells (Queiroz et al., 2017).